News|Articles|June 17, 2011

PQRI Risk-Management Case Studies: HACCP Training Tool Guidance

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Concept of EMA European Medicines Agency. Drugs evaluation and quality control department. | Image Credit: ©wladimir1804 -stock.adobe.com

EMA Director Sees Legislation Revamp as Highlight of 2025

BySusan Haigney

December 19th 2025

Ask the Expert: Training for a Skilled Workforce

BySusan J. Schniepp,Siegfried Schmitt,Susan Haigney

December 18th 2025

AI generative concept with businessman pointing on artificial intelligence to create prompt for command and generate ai to get output such as picture, music and video or data analysis | Image Credit: © AREE - stock.adobe.com

Accelerating HTA Readiness with Generative AI

ByAngeline Dhas

December 17th 2025

Lactose Monohydrate, is the sugar present in milk and its derivatives, it is a diluent excipient commonly used in the development of formulations to give volume to the pharmaceutical form | Image Credit: © RHJ -stock.adobe.com

Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence

ByJ. Mark Wiggins,Joseph A. Albanese,Gail Reed,Yelena Ionova

December 17th 2025

Pharmacist uses barcode reader to identify and sell a drug | Image Credit: ©alphaspirit -stock.adobe.com

Is Pharma Solving the Right Problem with its Data Transformation Efforts?

ByIan Crone

December 16th 2025

PQRI Risk-Management Case Studies: HACCP Training Tool Guidance

Newsletter

Related Content

EMA Director Sees Legislation Revamp as Highlight of 2025

Ask the Expert: Training for a Skilled Workforce

Accelerating HTA Readiness with Generative AI

Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence

Is Pharma Solving the Right Problem with its Data Transformation Efforts?

Trending on Pharmaceutical Technology

CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor

De-risking Biologic Development: Engineering Flexibility from Early Development to Launch

Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence

Momentum and Automation Driving Pharma Innovation and Digitalization Through 2026

Behind the Headlines Episode 30: 2026 Wish List